연구물
12건 검색
- 연구출판물 · 학술지 논문JCR Q3Scopus Q2Real-world experience of lenvatinib in patients with advanced anaplastic thyroid cancer
- 연구출판물 · 학술지 논문JCR Q2Scopus Q2KCI Q2Prognostic Roles of Inflammatory Biomarkers in Radioiodine-Refractory Thyroid Cancer Treated with Lenvatinib
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1A Phase Ib/IIa Study of Fostrox in Combination with Lenvatinib as Second-line Therapy in Patients with Advanced Hepatocellular Carcinoma
Chon, Hong Jae허정Kim, Do YoungLim, Ho YeongMacarulla, Teresa외 12명
- 연구출판물 · 학술지 논문JCR Q2Scopus Q2Real-world safety and effectiveness of lenvatinib in unresectable hepatocellular carcinoma in Korea: post-marketing study
Kang, WonseokKim, Yoon JunKim, Seung UpSeo, Yeon SeokKim, Jin-Wook윤기태외 13명
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Lenvatinib for Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma and Candidate Biomarkers Associated with Survival: A Multicenter Study in Korea
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1First safety and efficacy data from phase Ib/IIa study of fostroxacitabine bralpamide (fostrox, MIV-818) in combination with lenvatinib in patients with hepatocellular carcinoma (HCC).
Reig, MariaEvans, T.R. JeffryChon, Hong JaeLim, Ho YeongRyu, Min-Hee허정외 12명
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Lesion-Based Evaluation Predicts Treatment Response to Lenvatinib for Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Korean Multicenter Retrospective Study
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Extended Real-World Observation of Patients Treated with Sorafenib for Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma and Impact of Lenvatinib Salvage Treatment: A Korean Multicenter Study
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Lenvatinib Compared with Sorafenib as a First-Line Treatment for Radioactive Iodine-Refractory, Progressive, Differentiated Thyroid Carcinoma: Real-World Outcomes in a Multicenter Retrospective Cohort Study
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Durvalumab and tremelimumab, with or without lenvatinib, combined with transarterial chemoembolisation in participants with embolisation-eligible hepatocellular carcinoma (EMERALD-3): a global, randomised, open-label, sponsor-blinded, phase 3 study
Kudo, MasatoshiAbou-Alfa, Ghassan K.Ren, Zhenggang허정Lencioni, Riccardo외 21명
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1Real-World Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific Countries
Lee, Choong-kunYoo, ChanghoonHong, Jung YongPark, Se JunKim, Jin Won오상보외 24명
- 연구출판물 · 학술지 논문JCR Q2Scopus Q1Unusual metastases from differentiated thyroid cancers: A multicenter study in Korea



로그인
홈
Researcher Page
ISNI
ORCID